Pfizer Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7170811035
USD
27.16
0.35 (1.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
62,579.00
63,627.00
59,553.00
1,00,330.00
81,288.00
41,651.00
41,172.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
62,579.00
63,627.00
59,553.00
1,00,330.00
81,288.00
41,651.00
41,172.00
Raw Material Cost
21,544.00
21,781.00
29,213.00
38,240.00
34,413.00
11,771.00
12,623.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2,671.00
3,091.00
2,209.00
1,238.00
1,291.00
1,449.00
1,573.00
Selling and Distribution Expenses
13,682.00
14,625.00
14,470.00
13,115.00
12,254.00
11,400.00
12,674.00
Other Expenses
757.60
764.70
836.90
1,018.80
1,253.70
794.60
679.10
Total Expenditure (Excl Depreciation)
45,473.00
47,144.00
54,261.00
62,781.00
60,495.00
32,566.00
33,661.00
Operating Profit (PBDIT) excl Other Income
17106
16483
5292
37549
20793
9085
7511
Other Income
1,834.00
2,637.00
5,449.00
538.00
4,633.00
1,047.00
9,626.00
Operating Profit (PBDIT)
25,532.00
26,133.00
17,031.00
43,151.00
30,617.00
14,813.00
22,932.00
Interest
2,671.00
3,091.00
2,209.00
1,238.00
1,291.00
1,449.00
1,573.00
Exceptional Items
-8,749.00
-8,006.00
-7,474.00
-2,120.00
176.00
-1,645.00
-4,079.00
Gross Profit (PBDT)
41,035.00
41,846.00
30,340.00
62,090.00
46,875.00
29,880.00
28,549.00
Depreciation
6,592.00
7,013.00
6,290.00
5,064.00
5,191.00
4,681.00
5,795.00
Profit Before Tax
7,520.00
8,023.00
1,058.00
34,729.00
24,311.00
7,036.00
11,485.00
Tax
-267.00
-28.00
-1,114.00
3,328.00
1,852.00
370.00
618.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7,746.00
8,020.00
2,133.00
31,366.00
22,415.00
6,630.00
10,838.00
Extraordinary Items
0.00
0.00
0.00
0.00
-1.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
7,746.00
8,020.00
2,133.00
31,366.00
22,415.00
6,630.00
10,838.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
41.00
31.00
39.00
35.00
45.00
36.00
29.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7,787.00
8,051.00
2,172.00
31,401.00
22,460.00
6,666.00
10,867.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Reserves
86,476.00
88,203.00
89,014.00
95,661.00
77,201.00
63,238.00
63,126.00
Earnings per share (EPS)
1.36
1.41
0.37
5.47
3.88
1.63
2.87
Diluted Earnings per share
1.36
1.41
0.37
5.47
3.88
1.63
2.87
Operating Profit Margin (Excl OI)
27.34%
25.91%
8.89%
37.43%
25.58%
21.81%
18.24%
Gross Profit Margin
22.55%
23.63%
12.34%
39.66%
36.29%
28.13%
41.97%
PAT Margin
12.38%
12.6%
3.58%
31.26%
27.57%
15.92%
26.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -1.65% vs 6.84% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -3.28% vs 270.67% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 0.86% vs 102.87% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -13.59% vs 39.93% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Pfizer Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
62,579.00
64,926.00
-2,347.00
-3.61%
Other Operating Income
0.00
0.00
0.00
Total Operating income
62,579.00
64,926.00
-2,347.00
-3.61%
Raw Material Cost
21,544.00
18,195.00
3,349.00
18.41%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2,671.00
1,357.00
1,314.00
96.83%
Selling and Distribution Expenses
13,682.00
10,731.00
2,951.00
27.50%
Other Expenses
757.60
1,115.70
-358.10
-32.10%
Total Expenditure (Excl Depreciation)
45,473.00
41,440.00
4,033.00
9.73%
Operating Profit (PBDIT) excl Other Income
17,106.00
23,486.00
-6,380.00
-27.17%
Other Income
1,834.00
642.00
1,192.00
185.67%
Operating Profit (PBDIT)
25,532.00
29,966.00
-4,434.00
-14.80%
Interest
2,671.00
1,357.00
1,314.00
96.83%
Exceptional Items
-8,749.00
-1,704.00
-7,045.00
-413.44%
Gross Profit (PBDT)
41,035.00
46,731.00
-5,696.00
-12.19%
Depreciation
6,592.00
5,838.00
754.00
12.92%
Profit Before Tax
7,520.00
21,067.00
-13,547.00
-64.30%
Tax
-267.00
2,804.00
-3,071.00
-109.52%
Provisions and contingencies
0
0
0.00
Profit After Tax
7,746.00
18,254.00
-10,508.00
-57.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
7,746.00
18,254.00
-10,508.00
-57.57%
Share in Profit of Associates
0
0
0.00
Minority Interest
41.00
9.00
32.00
355.56%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7,787.00
18,263.00
-10,476.00
-57.36%
Equity Capital
0
0
0.00
Face Value
0.05
0.50
0.00
Reserves
86,476.00
52,606.00
33,870.00
64.38%
Earnings per share (EPS)
1.36
7.28
-5.92
-81.32%
Diluted Earnings per share
1.36
7.28
-5.92
-81.32%
Operating Profit Margin (Excl OI)
27.34%
36.17%
0.00
-8.83%
Gross Profit Margin
22.55%
41.44%
0.00
-18.89%
PAT Margin
12.38%
28.12%
0.00
-15.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 6,257.90 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -1.65% vs 6.84% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 778.70 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -3.28% vs 270.67% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,369.80 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.86% vs 102.87% in Dec 2024

Annual - Interest
Interest 267.10 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -13.59% vs 39.93% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.34%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024